Skip to Main content Skip to Navigation
Journal articles

Potent Inhibition of SARS-CoV-2 nsp14 N 7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues

Abstract : Enzymes involved in RNA capping of SARS-CoV-2 are essential for the stability of viral RNA, translation of mRNAs, and virus evasion from innate immunity, making them attractive targets for antiviral agents. In this work, we focused on the design and synthesis of nucleoside-derived inhibitors against the SARS-CoV-2 nsp14 (N7-guanine)-methyltransferase (N7-MTase) that catalyzes the transfer of the methyl group from the S-adenosyl-L-methionine (SAM) cofactor to the N7-guanosine cap. Seven compounds out of 39 SAM analogues showed remarkable double-digit nanomolar inhibitory activity against the N7-MTase nsp14. Molecular docking supported the structure−activity relationships of these inhibitors and a bisubstrate-based mechanism of action. The three most potent inhibitors significantly stabilized nsp14 (ΔT m ≈ 11 °C), and the best inhibitor demonstrated high selectivity for nsp14 over human RNA N7-MTase.
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03721688
Contributor : Jean-Jacques Vasseur Connect in order to contact the contributor
Submitted on : Tuesday, July 12, 2022 - 7:32:24 PM
Last modification on : Tuesday, September 27, 2022 - 4:39:27 AM

File

jmedchem Rostom 2022.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Rostom Ahmed-Belkacem, Marcel Hausdorff, Adrien Delpal, Priscila Sutto-Ortiz, Agathe M G Colmant, et al.. Potent Inhibition of SARS-CoV-2 nsp14 N 7-Methyltransferase by Sulfonamide-Based Bisubstrate Analogues. Journal of Medicinal Chemistry, American Chemical Society, 2022, 65 (8), pp.6231-6249. ⟨10.1021/acs.jmedchem.2c00120⟩. ⟨hal-03721688⟩

Share

Metrics

Record views

9

Files downloads

8